Avecure Flexible Microwave Ablation Probe For Lung Nodules
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Beth Israel Deaconess Medical Center
- Study ID
- NCT05281237
- Status
- Recruiting
Conditions
- Lung Cancer
- Lung Cancer Stage I
- Lung Cancer Stage II
- Stage I - II Primary Lung Cancer
- Stage I Lung Cancer
- Stage II Lung Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- AveCure 16 Gauge Flexible Microwave Ablation Probe — DEVICEMicrowave ablation of the solitary pulmonary nodule will be performed through a bronchoscopic approach using the AveCure Flexible Microwave Ablation Probe before surgery
Study Details
This research study to determine the effectiveness of the AveCure Flexible Microwave Ablation Probe to destroy cancerous lung nodules up to 3 c m in size. This research study involves microwave ablation (MWA)
Key Dates
- Start date
- Jun 1, 2022
- Status verified
- Apr 2026
- Primary completion
- Dec 30, 2026
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: AVECURE FLEXIBLE MICROWAVE ABLATION PROBE FOR LUNG NODULESThe research study procedures include screening for eligibility and study treatment including evaluations and follow up visits. * Ablation Procedure- MWA will be used to treat solitary pulmonary nodules up to 3cm. * CT scan will then be performed to evaluate the radiological changes 2 - 4 weeks after the ablation procedure. * Surgery will be performed to remove the lung nodule and the tissue will be evaluated by pathology.
Primary Outcome Measure
Rate of Planned Ablations. [ Time Frame: Day 1 ]
Central Contacts
- Jason Beattie, MD(617) 632- 8252
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02115 | Adnan Majid, MD (SUB_INVESTIGATOR) Mihir S Parikh, MD (SUB_INVESTIGATOR) Beattie Jason, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
By condition
By specialty
By research site
Related Studies
- DNA Analysis of Blood and Tissue from Patients with Lung CancerRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Molecular and Genetic Analysis of Lung CancerRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California